Rosuvastatin Tablet, Film Coated
Product Images NDC 50090-7730

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 50090-7730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 1)

This is a statistical data table displaying the results of a research study comparing an intervention (RSV) with a control group (Placebo). The results include Hazard Ratios (HR), 95% Confidence Intervals (CI), p-values, and the number of cases at risk over different years. The data indicates a significant difference between the two groups.*

FDA Label Image

Figure-02 (Figure 2)

The text provides data on the comparison between Rosuva 20 mg and Placebo 20 mg in a study with 8901 participants. The results show the hazard ratio and confidence intervals for various endpoints, such as the primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. Additionally, it includes information on event rates over one year, and defines cardiovascular death as including fatal MI, fatal stroke, sudden death, and other adjudicated causes of CV death.*

FDA Label Image

Figure-02 (Figure 3)

FDA Label Image

Label Image (Lbl500907730)

FDA Label Image

Structural Formula (Rosuvastatin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.